Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy

By Labrada Mayrel   Clavell Marilyn   Bebelagua Yanín   León Joel de   Alonso Daniel F   Gabri Mariano R   Veloso Roberto C   Vérez Vicente   Fernández Luis E  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 2, 2010-02 ,pp. : 153-162

Informa Healthcare

Access to resources Recommend Favorite

Ganglioside GM3 inhibition of EGF receptor mediated signal transduction

By Rebbaa Abdelhadi   Hurh Jay   Yamamoto Hirotaka   Kersey Donna S.   Bremer Eric G.  

Glycobiology, Vol. 6, Iss. 4, 1996-06 ,pp. : 399-406

Oxford University Press

Access to resources Recommend Favorite

Epidermal growth factor receptor glycosylation is required for ganglioside GM3 binding and GM3-mediated suppresion of activation

By Wang X-Q.  

Glycobiology, Vol. 11, Iss. 7, 2001-07 ,pp. : 515-522

Oxford University Press

Access to resources Recommend Favorite

The AP-2 transcription factor is required for the ganglioside GM3-stimulated transcriptional regulation of a PTEN gene

By Choi Hee-Jung   Chung Tae-Wook   Kim Seok-Jo   Cho Soo-Young   Lee Young-Seek   Lee Young-Choon   Ko Jeong-Heon   Kim Cheorl-Ho  

Glycobiology, Vol. 18, Iss. 5, 2008-05 ,pp. : 395-407

Oxford University Press

Access to resources Recommend Favorite

Endogenously produced ganglioside GM3 endows etoposide and doxorubicin resistance by up-regulating Bcl-2 expression in 3LL Lewis lung carcinoma cells

By Noguchi Mariko   Kabayama Kazuya   Uemura Satoshi   Kang Byoung-won   Saito Masaki   Igarashi Yasuyuki   Inokuchi Jin-ichi  

Glycobiology, Vol. 16, Iss. 7, 2006-07 ,pp. : 641-650

Oxford University Press

Access to resources Recommend Favorite